|
KIAA0232 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04570005379878E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29230000034397E-08 |
| Normal-vs-Stage2 |
3.344100E-03 |
| Normal-vs-Stage3 |
8.242500E-04 |
| Normal-vs-Stage4 |
8.661200E-03 |
| Stage1-vs-Stage2 |
8.706200E-01 |
| Stage1-vs-Stage3 |
7.063200E-01 |
| Stage1-vs-Stage4 |
7.611200E-01 |
| Stage2-vs-Stage3 |
7.028600E-01 |
| Stage2-vs-Stage4 |
6.990800E-01 |
| Stage3-vs-Stage4 |
9.676200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.48549999762815E-09 |
| Normal-vs-AfricanAmerican |
3.4491000000525E-07 |
| Normal-vs-Asian |
1.90858999999932E-05 |
| Caucasian-vs-AfricanAmerican |
8.963000E-01 |
| Caucasian-vs-Asian |
2.798400E-01 |
| AfricanAmerican-vs-Asian |
2.173800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78150050267334E-10 |
| Normal-vs-Female |
1.018710E-03 |
| Male-vs-Female |
2.638000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.54499999999569E-05 |
| Normal-vs-Extreme_Weight |
1.91860000109401E-08 |
| Normal-vs-Obese |
1.91367999999859E-05 |
| Normal-vs-Extreme_Obese |
2.007000E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.033800E-01 |
| Normal_Weight-vs-Obese |
5.382600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.796400E-01 |
| Extreme_Weight-vs-Obese |
2.455400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.795200E-01 |
| Obese-vs-Extreme_Obese |
7.663400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.66620000000106E-06 |
| Normal-vs-Age(41-60Yrs) |
3.89089999996983E-06 |
| Normal-vs-Age(61-80Yrs) |
1.26879995399065E-09 |
| Normal-vs-Age(81-100Yrs) |
5.033300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.134600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.769800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.722200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.773900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.231950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.253000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.25699999695439E-08 |
| Normal-VS-Type2 PRCC |
1.2524000003733E-07 |
| Normal-VS-KIRP CIMP |
1.11389999446487E-08 |
| Normal-VS-Unclassified PRCC |
1.919500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.605800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.742300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.499400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.085950E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.724200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.304100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.34170485622099E-11 |
| Normal-vs-N1 |
6.543200E-03 |
| Normal-vs-N2 |
1.176060E-02 |
| N0-vs-N1 |
3.140800E-01 |
| N0-vs-N2 |
3.782000E-01 |
| N1-vs-N2 |
9.543200E-01 |
|
|
